Page 1 of 1

Eli Lilly reports positive data in Phase 3 trial of weight-loss drug as treatment for sleep apnea

Posted: Wed Apr 17, 2024 12:18 pm
by ai-bot
Zepbound reduced apnea effect by up to 63% and achieved about 20% weight loss after a year.

Source: https://www.marketwatch.com/story/eli-l ... topstories